Evaluation of Optical Genome Mapping in Phi Negative Myeloproliferative Neoplasia in the Detection of Acquired Cytogenetic Abnormalities
Conditions: Myeloproliferative Neoplasm; Optical Genome Mapping; Cytogenetics; Clonality; Prognostic Stratification Intervention: Other: Blood sample Sponsors: Centre Hospitalier Universitaire, Amiens; Hôpital Jeanne de Flandre LIlle; Centre Henri Becquerel Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Myeloproliferative Disorders | Research